Limestone Report: US-10874661-B2
Possible Classes | 507 |
Recommended Classes | 127 |
Government Assigned Classes | 14 |
CPC | Title | Score |
|---|---|---|
| A61K31/485 | Morphinan derivatives e.g. morphine codeine | ●●●●● |
| A61K31/454 | containing a five-membered ring with nitrogen as a ring hetero atom e.g. pimozide domperidone | ●●●●● |
| A61K9/006 | Oral mucosa e.g. mucoadhesive forms sublingual droplets| Buccal patches or films| Buccal sprays | ●●●●● |
| A61K9/0056 | Mouth soluble or dispersible forms| Suckable eatable chewable coherent forms| Forms rapidly disintegrating in the mouth| Lozenges| Lollipops| Bite capsules| Baked products| Baits or other oral forms for animals | ●●●●● |
| A61K9/0019 | Injectable compositions| Intramuscular intravenous arterial subcutaneous administration| Compositions to be administered through the skin in an invasive manner | non-active ingredients are additionally classified in | (ref: A61K47/00) | ●●●●● |
| C07D489/12 | the bridge containing only two carbon atoms | ●●●●● |
| A61K9/0002 | Galenical forms characterised by the drug release technique| Application systems commanded by energy | ●●●●● |
| A61K9/08 | Solutions | composition of solutions | (ref: A61K47/00) | ●●●●● |
| A61K9/7007 | Drug-containing films membranes or sheets | (ref: A61K9/0041)| | (ref: A61K9/0043)| | (ref: A61K9/006)| | (ref: A61K9/0063)| take precedence | ●●●●● |
| A61K9/0014 | Skin i.e. galenical aspects of topical compositions | non-active ingredients are additionally classified in | (ref: A61K47/00)| | | (ref: A61K9/0009)| | (ref: A61K9/0021)| | (ref: A61K9/7015)| | (ref: A61K9/7023)| take precedence| cosmetic preparations | (ref: A61K8/00)| | (ref: A61Q)| | preparations for wound dressings or bandages | (ref: A61L26/00) | ●●●●● |
| ●●●●● | ●●●●● | ●●●●● |
| ●●●●● | ●●●●● | ●●●●● |
| ●●●●● | ●●●●● | ●●●●● |
ncG1vNJzZmirY2Ourq3ZqKWar6NjsLC5jqucqaeiqXuttcyeqq2nnpq2sXrCqKRol3KXvqzFsLGwfGpybaFztdagp4mtj2Ovor%2FInGWhrJ2h
Sebrina Pilcher
Update: 2024-04-13